$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Dec 3, 2025)
$79.09M
Market Cap
-
P/E Ratio
-2.6
EPS
$9.36
52 Week High
$0.52
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Sutro Biopharma, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, specializing in the discovery and development of innovative antibody-drug conjugates (ADCs) through its proprietary cell-free protein synthesis technology. The company is focused on advancing a diverse pipeline of targeted therapies aimed at treating cancer and other serious diseases, leveraging its expertise in protein engineering and biologics manufacturing. Sutro's commitment to precision medicine positions it strategically for growth and potential partnerships in the dynamic biopharmaceutical sector, addressing critical unmet medical needs.
LPTX
VRAX
VHAI
IPG
IRBT
ASST
NVDA
ADAP
MARA
DNN
PFE
NIO
ITUB
BYND
INTC
PLTD
VALE
TSLA
MTSR
RR
NFLX
BA
IREN
LUMN
AMCR
PMAX
MRVL
HTOO
SOFI
BITF
PLUG
KDLY
AAL
SAND
BMY
CDE
AUR
SHOT
ZAPP
NCLH
CAPR
ARTL
ASBP
HIMS
CIFR
AMD
ALIT
CPNG
AEO
PSTG
DKNG
WULF
ASAN
GOOGL
HOOD
GM
TEVA
APH
M
CLSK
IVP
GTLB
QBTS
VGFC
LPTX
VRAX
VHAI
IPG
IRBT
ASST
NVDA
ADAP
MARA
DNN
PFE
NIO
ITUB
BYND
INTC
PLTD
VALE
TSLA
MTSR
RR
NFLX
BA
IREN
LUMN
AMCR
PMAX
MRVL
HTOO
SOFI
BITF
PLUG
KDLY
AAL
SAND
BMY
CDE
AUR
SHOT
ZAPP
NCLH
CAPR
ARTL
ASBP
HIMS
CIFR
AMD
ALIT
CPNG
AEO
PSTG
DKNG
WULF
ASAN
GOOGL
HOOD
GM
TEVA
APH
M
CLSK
IVP
GTLB
QBTS
VGFC